New model may pinpoint timing of final menstrual period

March 26, 2013, The Endocrine Society

For women enduring hot flashes and other symptoms of menopause, a new model could better estimate the timing of the final menstrual period, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Researchers at the University of California, Los Angeles (UCLA) developed a formula using the levels of two hormones to estimate when the final menstrual period would occur. The calculation relies on changing levels of estradiol, a hormone present in the ovary, and follicle stimulating hormone, a hormone in the brain that gives instructions to the ovary. As go through menopause, follicle stimulating hormone levels rise and estradiol levels dip.

Currently, physicians monitor bleeding patterns to determine the menopause transition stage. However, the menopause transition stage is a very imprecise predictor of when the final menstrual period will take place. More than 60 percent of women who are classified as early perimenopausal – meaning that their periods are less predictable but they have no big gaps in cycles – become postmenopausal without any additional clinical bleeding signal.

"We need a better way to answer women's questions about when to expect the final menstrual period." said lead author Gail Greendale, M.D., of UCLA's David Geffen School of Medicine. "If further research bears out our approach, it could be the first step to developing web-based calculators and other tools women can use to estimate where they are in the and how far away their final period is."

The researchers analyzed longitudinal data from 554 women taking part in the National Institutes of Health's Study of Women's Health Across the Nation to develop the model.

Being able to predict the final menstrual period could have broader implications for women's health, Greendale said. In the year leading up to the final menstrual period, women face accelerated bone loss and increased cardiovascular risk.

"For example, some researchers have proposed that an intervention begun one or two years before the final would greatly decrease future fracture risk by preventing the very rapid bone loss that occurs in the few years before and few years after the final menses," Greendale said. "But before ideas such as this can be tested, we need to accurately predict where a woman is in her timeline to ."

Explore further: Researchers zero in on cognitive difficulties associated with menopause

More information: The article, "Predicting the Timeline to the Final Menstrual Period: the Study of Women's Health Across the Nation," appears in the April 2013 issue of JCEM.

Related Stories

Researchers zero in on cognitive difficulties associated with menopause

January 3, 2013
The memory problems that many women experience in their 40s and 50s as they approach and go through menopause are both real and appear to be most acute during the early period of post menopause. That is the conclusion of ...

Age at first menstrual cycle, menopause tied to heart disease risk

March 7, 2013
–Chinese women are less likely to develop cardiovascular disease if they have their first menstrual cycle or enter menopause later than their peers, according to a recent study accepted for publication in The Endocrine ...

Recommended for you

Study shows how fetal infections may cause adult heart disease

January 23, 2018
Recent studies have shown that infants born prematurely have a higher risk of developing heart disease later in life. Now, a study led by researchers at the University of Washington School of Medicine in Seattle shows that, ...

Rise in preterm births linked to clinical intervention

January 18, 2018
Research at the University of Adelaide shows preterm births in South Australia have increased by 40 percent over 28 years and early intervention by medical professionals has resulted in the majority of the increase.

New report calls into question effectiveness of pregnancy anti-nausea drug

January 17, 2018
Previously unpublished information from the clinical trial that the U.S. Food and Drug Administration relied on to approve the most commonly prescribed medicine for nausea in pregnancy indicates the drug is not effective, ...

New study finds 'baby brain' is real, but the cause remains mysterious

January 15, 2018
So-called "baby brain" refers to increased forgetfulness, inattention, and mental "fogginess" reported by four out of five pregnant women. These changes in brain function during pregnancy have long been recognised in midwifery ...

Sleep quality improves with help of incontinence drug

January 12, 2018
A drug used to curtail episodes of urinary incontinence in women also improves quality of sleep, a researcher at the Stanford University School of Medicine reports.

Frozen embryos result in just as many live births in IVF

January 10, 2018
Freezing and subsequent transfer of embryos gives infertile couples just as much of a chance of having a child as using fresh embryos for in vitro fertilization (IVF), research from Ho Chi Minh City, Vietnam, and Adelaide, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.